Meet Artialis at OARSI 2017
We kindly invite you to meet us during the OARSI 2017 World Congress.
Meet Artialis at BIO-Europe Spring® 2017
Artialis welcomes Ali Baladi as Chief Financial Officer
Artialis SA is pleased to announce the appointment of Ali Baladi as Chief Financial Officer. Mr Baladi, former Vice President-Vaccines cluster Lead Europe in Pfizer Inc., has joined the Company effective 16 January 2017.
We needed a specific measure for the cartilage degeneration to prove the efficacy of our product. The collaboration with Artialis was a logical choice
Sales & Marketing Director, Tilman (Belgium)
We wanted to know whether oral treatment with polyphenols could decreased serum level of OA biomarkers in DMM mice model and needed results quickly. [Artialis has offered] robust skills, reactivity, and possibility to academic collaboration.
PhD candidate, INSERM U791, Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (France)
“We chose Artialis because of their expertise in the design of in vivo protocol specialized in osteoarthritis. Moreover, it was very well written and Artialis team inspired a lot of confidence.
[We liked] their dedication to our project, their knowledge in osteoarthritis, their access to a state of the art animal facility, [and] their knowledge in in vivo design protocol (…) I would highly recommend the services of Artialis mainly for their high quality and high involvement.”
R&D Project Manager, Confidential Customer